Albanell J - Search Results

1

Fulvestrant-Palbociclib vs Letrozole-Palbociclib as Initial Therapy for Endocrine-Sensitive, Hormone Receptor-Positive, ERBB2-Negative Advanced Breast Cancer: A Randomized Clinical Trial.

Llombart-Cussac A, Pérez-García JM, Bellet M, Dalenc F, Gil-Gil M, Ruíz-Borrego M, Gavilá J, Sampayo-Cordero M, Aguirre E, Schmid P, Marmé F, Di Cosimo S, Gligorov J, Schneeweiss A, Albanell J, Zamora P, Wheatley D, Martínez-de Dueñas E, Amillano K, Malfettone A, Cortés J; PARSIFAL Steering Committee and Trial Investigators. Llombart-Cussac A, et al. Among authors: albanell j. JAMA Oncol. 2021 Dec 1;7(12):1791-1799. doi: 10.1001/jamaoncol.2021.4301. JAMA Oncol. 2021. PMID: 34617955 Free PMC article. Clinical Trial.

2

The use of taxanes in the neoadjuvant treatment of breast cancer: a review of randomized phase II/III trials.

Tusquets I, Estévez LG, Alvarez I, Muñoz M, Adrover E, Albanell J, Rodríguez C, Seguí MA, Rodríguez-Lescure A, Ruiz-Borrego M, García-Mata J, Lluch A. Tusquets I, et al. Among authors: albanell j. Clin Breast Cancer. 2007 Oct;7(10):764-74. doi: 10.3816/cbc.2007.n.037. Clin Breast Cancer. 2007. PMID: 18021477 Review.

3

Phenotypic characterization and risk factors for interval breast cancers in a population-based breast cancer screening program in Barcelona, Spain.

Domingo L, Sala M, Servitja S, Corominas JM, Ferrer F, Martínez J, Macià F, Quintana MJ, Albanell J, Castells X. Domingo L, et al. Among authors: albanell j. Cancer Causes Control. 2010 Aug;21(8):1155-64. doi: 10.1007/s10552-010-9541-6. Epub 2010 Mar 28. Cancer Causes Control. 2010. PMID: 20349271

4

Vitamin D deficiency and bone mineral density in postmenopausal women receiving aromatase inhibitors for early breast cancer.

Nogues X, Servitja S, Peña MJ, Prieto-Alhambra D, Nadal R, Mellibovsky L, Albanell J, Diez-Perez A, Tusquets I. Nogues X, et al. Among authors: albanell j. Maturitas. 2010 Jul;66(3):291-7. doi: 10.1016/j.maturitas.2010.03.012. Epub 2010 Apr 15. Maturitas. 2010. PMID: 20399042

5

Vitamin D threshold to prevent aromatase inhibitor-induced arthralgia: a prospective cohort study.

Prieto-Alhambra D, Javaid MK, Servitja S, Arden NK, Martinez-García M, Diez-Perez A, Albanell J, Tusquets I, Nogues X. Prieto-Alhambra D, et al. Among authors: albanell j. Breast Cancer Res Treat. 2011 Feb;125(3):869-78. doi: 10.1007/s10549-010-1075-9. Epub 2010 Jul 28. Breast Cancer Res Treat. 2011. PMID: 20665105

6

Nuclear NF-κB/p65 expression and response to neoadjuvant chemotherapy in breast cancer.

Jones RL, Rojo F, A'Hern R, Villena N, Salter J, Corominas JM, Servitja S, Smith IE, Rovira A, Reis-Filho JS, Dowsett M, Albanell J. Jones RL, et al. Among authors: albanell j. J Clin Pathol. 2011 Feb;64(2):130-5. doi: 10.1136/jcp.2010.082966. Epub 2010 Dec 8. J Clin Pathol. 2011. PMID: 21148141

7

Bone health in a prospective cohort of postmenopausal women receiving aromatase inhibitors for early breast cancer.

Servitja S, Nogués X, Prieto-Alhambra D, Martínez-García M, Garrigós L, Peña MJ, de Ramon M, Díez-Pérez A, Albanell J, Tusquets I. Servitja S, et al. Among authors: albanell j. Breast. 2012 Feb;21(1):95-101. doi: 10.1016/j.breast.2011.09.001. Epub 2011 Sep 15. Breast. 2012. PMID: 21924904 Free article.

8

Pertuzumab monotherapy after trastuzumab-based treatment and subsequent reintroduction of trastuzumab: activity and tolerability in patients with advanced human epidermal growth factor receptor 2-positive breast cancer.

Cortés J, Fumoleau P, Bianchi GV, Petrella TM, Gelmon K, Pivot X, Verma S, Albanell J, Conte P, Lluch A, Salvagni S, Servent V, Gianni L, Scaltriti M, Ross GA, Dixon J, Szado T, Baselga J. Cortés J, et al. Among authors: albanell j. J Clin Oncol. 2012 May 10;30(14):1594-600. doi: 10.1200/JCO.2011.37.4207. Epub 2012 Mar 5. J Clin Oncol. 2012. PMID: 22393084 Clinical Trial.

9

Vitamin D threshold to prevent aromatase inhibitor-related bone loss: the B-ABLE prospective cohort study.

Prieto-Alhambra D, Servitja S, Javaid MK, Garrigós L, Arden NK, Cooper C, Albanell J, Tusquets I, Diez-Perez A, Nogues X. Prieto-Alhambra D, et al. Among authors: albanell j. Breast Cancer Res Treat. 2012 Jun;133(3):1159-67. doi: 10.1007/s10549-012-2013-9. Epub 2012 Mar 21. Breast Cancer Res Treat. 2012. PMID: 22434523

10

Factors affecting 5- and 10-year survival of women with breast cancer: an analysis based on a public general hospital in Barcelona.

Macià F, Porta M, Murta-Nascimento C, Servitja S, Guxens M, Burón A, Tusquets I, Albanell J, Castells X. Macià F, et al. Among authors: albanell j. Cancer Epidemiol. 2012 Dec;36(6):554-9. doi: 10.1016/j.canep.2012.07.003. Epub 2012 Jul 31. Cancer Epidemiol. 2012. PMID: 22854422

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

261 results

Search Page